Drug safety hotlines have operated the same way for decades. An agent picks up a call, listens, and types what they hear into a case management system. When the call ends, they review their notes, fill in gaps, and route the case for medical review. It is a process built on human attention and manual transcription — and it has not fundamentally changed since PV call centres first came into existence.
The volume of adverse event reports, however, has increased. Global drug portfolios now generate case volumes growing to 20% annually. A serious adverse event reported at 11 PM in one time zone triggers regulatory obligations that don’t wait for business hours in another. And a missed or inaccurately transcribed seriousness criterion can have consequences that reach from the case record all the way to a regulatory inspection.
This is the operational context in which AWS Connect telephony for pharmacovigilance is gaining serious attention from drug safety teams. Not as a replacement for qualified PV professionals, but as an infrastructure layer that removes the manual bottlenecks before, during, and after the call — so professionals can focus on work that actually requires them.
This blog outlines how a connected, AI-powered intake architecture can transform pharmacovigilance case intake from first contact through structured extraction and case creation.
What AWS Connect Brings to PV Telephony
AWS Connect is a cloud-based contact centre platform built on the same infrastructure that powers Amazon’s own customer operations. For pharmacovigilance, its relevance lies not in its call routing capabilities alone, but in what it enables when a purpose-built PV intelligence layer is placed on top of it.
The standard drug safety hotline model has three consistent weaknesses:
- Transcription dependency - Everything the caller says passes through a human transcriber before it becomes case data. Every error at this stage propagates forward into the case record, the safety database, and ultimately the regulatory submission
- Sequential processing - Calls are handled, then transcribed, then reviewed, then classified, then entered. Each stage waits for the previous one to complete
- Reactive prioritisation - A serious adverse event sits in the same queue as a routine medical inquiry until a human reads far enough into the case to identify the difference
-
Integrate with signal management platforms.
AWS Connect, integrated with AI-powered voice analytics for adverse event reporting, addresses all three simultaneously. Real-time speech-to-text converts the conversation as it happens. NLP trained on pharmacovigilance terminology, including drug names, MedDRA-aligned event descriptions, seriousness indicators, and causality language, classifies the content concurrently with the call. Intelligent routing decisions are made before the call ends, not after it has been manually reviewed.
The result is a telephony environment where the infrastructure itself is doing pharmacovigilance work, in addition to connecting calls.
Real-Time Voice Analytics: What Actually Happens on a Call
When a reporter calls a drug safety line on AWS Connect with an integrated PV platform, the agent is free to focus entirely on the conversation, not on transcribing it. Here is what the system is doing in parallel:
- Real-time speech-to-text converts the caller's words as they are spoken, not as a post-call batch process
- NLP extracts key safety fields concurrently: suspect drug, adverse event description, patient demographics, dose details, and temporal relationships, structured as the call progresses
- Confidence scoring flags which extractions are high-confidence and which require human verification
- Intelligent pre-population of case forms before the call ends, reducing data entry by 85%, with reviewers validating entries rather than constructing records from scratch
- Real-time QA checks alert the agent if critical fields are missing, reducing quality review cycles by 55%
AI-powered case intake for drug safety built on this infrastructure reduces data entry errors by 80%. The agent is no longer the single point of failure for data accuracy.
Intelligent Call Routing and Case Prioritisation
Intelligent call routing in pharmacovigilance via AWS Connect is meaningfully different from standard contact centre routing. In a conventional MICC, calls are routed based on availability. A life-threatening reaction and a routine product query join the same queue, their urgency undetermined until a human engages with both.
With AI-driven routing, classification begins as the call connects. By the time the system identifies the call type (serious AE, non-serious AE, medical inquiry, product quality complaint), the routing decision is already made. Serious adverse events bypass standard queues entirely.
The downstream impact: average call duration reduces by 30%, and intelligent case prioritisation based on severity, urgency, and medical importance reduces time-to-reporting for serious adverse events from days to hours. The 15-day expedited reporting clock under FDA 21 CFR 314.80 and EMA GVP Module VI starts at first receipt, not at queue clearance. Every hour saved between those two points counts toward compliance.
PDF and Form-Based Case Intake: The Same Intelligence, Different Channel
Telephony is one intake channel. For many PV operations, documents, including PDFs, structured forms, and affiliate submissions, represent an equal or greater volume of incoming cases.
PDF Intake
Unstructured PDF safety narratives are among the hardest documents to process manually. An NLP-based extraction layer handles this by:
- Identifying the four ICSR minimum criteria: identifiable patient, suspect drug, adverse event, and reporter
- Extracting and structuring relevant safety fields from free-text narrative
- Mapping adverse event terms to MedDRA before the document reaches a human reviewer
- Reducing manual review time by 70%
Structured Form Intake
Structured forms arrive with defined fields, but that does not make them low-effort. CIOMS forms, MedWatch forms, SAE forms, and custom affiliate submissions from partners and CROs introduce their own challenges:
- High volume with inconsistent formatting across submitters
- MedDRA coding requirements that vary by form type
- Partner-specific field mapping that needs standardisation before case creation
Automated ingestion handles extraction and validation, routing each form through the same triage workflow as telephony and PDF intake — feeding into a unified case record regardless of source.
Multi-Language Support Without Multilingual Staffing
A global pharmacovigilance programme captures adverse events in dozens of languages. EMA’s GVP Module VI and FDA reporting requirements do not make allowances for cases reported in languages an organisation’s intake team doesn’t cover.
Multi-language adverse event case intake on AWS Connect handles this through automatic language detection at the point of intake, for both telephony and documents. The design principle is extraction-first, not translation-first: structured, MedDRA-coded fields are extracted directly from source content regardless of language. This expands global reach without requiring multilingual staffing at every intake point, a significant operational advantage for multi-market portfolios.
HIPAA, GDPR, and Audit-Ready Operations
HIPAA and GDPR compliant PV telephony requires more than selecting a compliant platform. It requires deliberate configuration at every layer. AWS Connect is HIPAA-eligible. The PV implementation layer determines whether that eligibility translates into actual compliance. In a properly configured deployment:
- All call recordings, extracted case data, and document content are encrypted in transmission and at rest
- PII is redacted before data passes into shared environments or downstream integrations
- Role-based access controls restrict identifiable patient data to authorised personnel only
- Audit trails are generated continuously, covering call receipt, NLP extraction, confidence scoring, human validation, and case submission, as computer-generated, time-stamped records compliant with 21 CFR Part 11 and EU GMP Annex 11
Regulators don’t ask whether AI was used. They ask whether every AI-assisted decision is documented, traceable, and defensible. A properly integrated deployment generates that documentation as part of normal operations, not as a preparation exercise.
How Clinevo's Case Intake Platform Connects the Full Pipeline
Clinevo’s Case Intake platform is not a point solution for a single channel. It is a connected architecture that spans every intake touchpoint in a global PV operation:
Every channel feeds into the same unified case record. Every stage is documented. Human oversight is built in at the point that actually requires it — validation, causality assessment, and final submission sign-off — not at the data entry and extraction stages that automation handles more consistently and at far greater speed.
Clinevo’s Case Intake platform is part of a broader pharmacovigilance product suite that includes Clinevo Safety (PV database), Signal Detection, Literature Automation, and Clinevo SDEA — designed to support end-to-end drug safety operations from first receipt through regulatory submission. The Case Intake platform integrates directly with Clinevo Safety as well as third-party PV databases, ensuring that validated cases transfer without manual re-entry and that audit trail continuity is maintained across the full pipeline.
Frequently Asked Questions
Pharma companies are embedding AI voice analytics into drug safety hotline infrastructure built on AWS Connect. A PV-trained NLP engine identifies suspect drugs, adverse event descriptions, patient demographics, and seriousness indicators in real time, concurrently with the conversation.
By the time a call ends, a draft case record is pre-populated and confidence-scored. The agent shifts from transcription to confirmation, reducing data entry errors by 80% and allowing the same team to handle significantly more cases without proportional headcount growth.
ROI shows up in two places: time and compliance. Pharmacovigilance automation reduces processing time by 50%. For expedited cases, real-time seriousness classification means serious events reach reviewers in minutes — directly compressing the window before the 15-day deadline. On the compliance side, automated audit trails, consistent MedDRA coding, and E2B R3 field mapping reduce inspection risk from documentation gaps — consequences that far exceed the cost of the platform.
Reliability depends on architecture. A translation-first approach introduces interpretive risk. Clinical terminology doesn't map cleanly across languages. The reliable model is extraction-first: MedDRA-coded fields are extracted directly from source content regardless of language. Automatic language detection at intake, for both telephony and documents, expands global reach without requiring multilingual staffing at every intake point.
AWS Connect is a HIPAA-eligible service, but eligibility is not the same as compliance. Configuration determines that. Core practices: encrypt all call recordings and case data at rest and in transit; apply PII redaction before data passes into shared environments; enforce role-based access controls with complete audit trails; and ensure pipeline-wide audit trail generation as computer-generated, time-stamped records under 21 CFR Part 11 and EU GMP Annex 11. A properly integrated deployment generates inspection-ready documentation continuously, not assembled before an audit.
It can. NLP classifies call content in real time, applying seriousness criteria as the caller describes them. When a case meets expedited criteria, intelligent routing diverts it immediately to a qualified reviewer, bypassing the standard queue. The 15-day reporting clock starts at first receipt, not queue clearance. Intelligent case prioritisation based on severity and medical importance reduces time-to-reporting for serious adverse events from days to hours. That is a regulatory compliance outcome, not an efficiency improvement.
